BATTAGLIA, GIUSEPPE
 Distribuzione geografica
Continente #
NA - Nord America 1.191
EU - Europa 882
AS - Asia 163
Totale 2.236
Nazione #
US - Stati Uniti d'America 1.189
GB - Regno Unito 389
IE - Irlanda 177
CN - Cina 103
UA - Ucraina 81
SE - Svezia 74
IT - Italia 59
FR - Francia 40
TR - Turchia 22
VN - Vietnam 22
FI - Finlandia 19
DE - Germania 15
ES - Italia 13
BE - Belgio 11
IN - India 9
IR - Iran 5
AT - Austria 2
BD - Bangladesh 2
CA - Canada 2
LT - Lituania 1
PL - Polonia 1
Totale 2.236
Città #
Southend 361
Fairfield 193
Dublin 173
Chandler 104
Ann Arbor 94
Ashburn 91
Wilmington 79
Woodbridge 73
Menlo Park 72
Seattle 66
Houston 63
Jacksonville 63
Cambridge 57
Siena 42
Beijing 30
New York 26
Princeton 24
Dong Ket 22
Izmir 22
Dearborn 19
Fremont 18
Helsinki 13
Málaga 13
Brussels 11
Nanjing 11
Boardman 9
San Mateo 8
Shanghai 8
San Diego 7
Shenyang 7
Hebei 6
Nanchang 6
Jiaxing 5
Tianjin 5
Zanjan 5
Falls Church 4
Florence 4
Phoenix 4
Fort Worth 3
Jinan 3
Kunming 3
Lancaster 3
Changsha 2
Dhaka 2
Lanzhou 2
Ningbo 2
Priocca 2
Sezze 2
Taizhou 2
Vienna 2
Wuhan 2
Zhengzhou 2
Andover 1
Bangalore 1
Caserta 1
Chaoyang 1
College Station 1
Edinburgh 1
Fuzhou 1
Guangzhou 1
Hangzhou 1
Henderson 1
Hounslow 1
Katy 1
Kilburn 1
Kyiv 1
London 1
Montreal 1
Nagold 1
Philadelphia 1
Redwood City 1
Saint Louis 1
San Francisco 1
Selargius 1
Shenzhen 1
Warsaw 1
Washington 1
Winnipeg 1
Totale 1.876
Nome #
Anti-cancer activity of dose-fractioned mPE +/- bevacizumab regimen is paralleled by immune-modulation in advanced squamous NSLC patients 239
Phase Ib study of poly-epitope peptide vaccination to thymidylate synthase (TSPP) and GOLFIG chemo-immunotherapy for treatment of metastatic colorectal cancer patients 224
3D bone texture analysis as a potential predictor of radiationinduced insufficiency fractures 197
Perilesional edema in brain metastasis from non-small cell lung cancer (NSCLC) as predictor of response to radiosurgery (SRS) 191
Texture analysis as a predictor of radiation-induced xerostomia in head and neck patients undergoing IMRT 179
Immuno-Inflammatory Markers in Advanced NSCLC Patients Undergone Fractioned Cisplatin, Oral Etoposide and Bevacizumab 171
Patients Affected by Unmethylated O(6)-Methylguanine-DNA Methyltransferase Glioblastoma Undergoing Radiochemotherapy May Benefit from Moderately Dose-Escalated Radiotherapy 151
Epidermal Growth Factor Receptor Expression predicts Time and Patterns of Recurrence in Glioblastoma Patients Following Radiotherapy and Temozolomide. 150
Radiotherapy prolongs the survival of advanced non-small-cell lung cancer patients undergone to an immune-modulating treatment with dose-fractioned cisplatin and metronomic etoposide and bevacizumab (mPEBev). 144
null 139
null 130
null 117
null 82
Combined epidermal growth factor receptor and beclin1 autophagic protein expression analysis identifies different clinical presentations, responses to chemo- and radiotherapy, and prognosis in glioblastoma 48
Bone texture analysis using CT-simulation scans to individuate risk parameters for radiation-induced insufficiency fractures. 45
Prognostic Value of MR Imaging Texture Analysis in Brain Non-Small Cell Lung Cancer Oligo-Metastases Undergoing Stereotactic Irradiation. 43
In Regard to Kubicek et al. 38
Totale 2.288
Categoria #
all - tutte 5.567
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.567


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019177 0 0 0 0 0 0 0 0 0 0 100 77
2019/2020525 58 14 29 70 37 51 54 61 57 49 18 27
2020/2021412 15 72 5 36 24 47 13 50 24 60 15 51
2021/2022235 23 22 19 13 14 12 15 17 14 20 23 43
2022/2023315 17 36 49 50 30 48 4 24 26 18 5 8
2023/2024254 2 4 21 10 5 80 128 0 2 2 0 0
Totale 2.288